Show Summary Details
Page of

The lung in autoimmune rheumatic disorders 

The lung in autoimmune rheumatic disorders
The lung in autoimmune rheumatic disorders

M.A. Kokosi

, and A.U. Wells

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 March 2021

Lung complications occur in all rheumatological disorders, but their frequency and type vary strikingly between different systemic diseases. Interstitial lung disease and pulmonary vascular disease are now increasingly recognized, although the detection of limited abnormalities poses difficulties for clinicians who must now distinguish between subclinical involvement and clinically significant disease. The presence or absence of exertional dyspnoea is often misleading as musculoskeletal limitation may mask respiratory symptoms or, alternatively, may cause exercise intolerance without lung pathology, due to the increased work associated with inefficient locomotion. Furthermore, interstitial lung disease precedes the onset of systemic disease in some cases, although typical autoantibody profiles are often diagnostic.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.